Abstract:The pathophysiology of vasovagal syncope is poorly understood, and the treatment usually ineffective. Our clinical experience is that patients with vasovagal syncope fall into 2 groups, based on their supine systolic blood pressure, which is either normal (>100 mm Hg) or low (70-100 mm Hg). We investigated neural circulatory control in these 2 phenotypes.Sympathetic nervous testing was at 3 levels: electric, measuring sympathetic nerve firing (microneurography); neurochemical, quantifying norepinephrine spillover to plasma; and cellular, with Western blot analysis of sympathetic nerve proteins. Testing was done during head-up tilt (HUT), simulating the gravitational stress of standing, in 18 healthy control subjects and 36 patients with vasovagal syncope, 15 with the low blood pressure phenotype and 21 with normal blood pressure. Microneurography and norepinephrine spillover increased significantly during HUT in healthy subjects. The microneurography response during HUT was normal in normal blood pressure and accentuated in low blood pressure phenotype (P=0.05). Norepinephrine spillover response was paradoxically subnormal during HUT in both patient groups (P=0.001), who thus exhibited disjunction between nerve firing and neurotransmitter release; this lowered norepinephrine availability, impairing the neural circulatory response. Subnormal norepinephrine spillover in low blood pressure phenotype was linked to low tyrosine hydroxylase (43.7% normal, P=0.001), rate-limiting in norepinephrine synthesis, and in normal blood pressure to increased levels of the norepinephrine transporter (135% normal, P=0.019), augmenting transmitter reuptake.Patients with recurrent vasovagal syncope, when phenotyped into 2 clinical groups based on their supine blood pressure, show unique sympathetic nervous system abnormalities. It is predicted that future therapy targeting the specific mechanisms identified in the present report should translate into more effective treatment.

Towards Understanding the Genetic Nature of Vasovagal Syncope

Vasovagal syncope: An overview of pathophysiological mechanisms

Search for Epistatically Interacting Genetic Variants That Are Associated with Vasovagal Syncope within Biallelic Combinations

Association of Polymorphic Genome Variants in the 2q32.1 Locus with the Development of Vasovagal Syncope

Alteration of Gene Expression Profiling Including GPR174 and GNG2 is Associated with Vasovagal Syncope

The pathophysiology of vasovagal syncope: Novel insights

The Role of the Autonomic Nervous System in Vasovagal Syncope

Is vasovagal syncope a disease?

Selective Anatomical Catheter Ablation of Left Atrial Ganglionated Plexus for Vasovagal Syncope: Left Superior and Right Anterior Ganglionated Plexus Ablation

Likelihood of injury due to vasovagal syncope: a systematic review and meta-analysis

Role of Β1-Adrenoceptor Gene ADRB1Ser49Gly Polymorphism in Patients with Vasovagal Syncope

Relationship between hemodynamic type and syncopal symptoms in pediatric vasovagal syncope

Recurrent Postural Vasovagal Syncope

Sex and age impact prevalence and symptoms of vasovagal syncope: Implications for accurate diagnosis

Genetic variants associated with syncope implicate neural and autonomic processes

Neural Control Mechanisms and Vasovagal Syncope

Research progress on the predictive value of electrocardiographic indicators in the diagnosis and prognosis of children with vasovagal syncope

Advances in the role of vascular endothelial system in the pathogenesis of vasovagal syncope in children

Analysis of the factors related to recurrent vasovagal syncope in children

Vasovagal Syncope: A Review of Current and Emerging Therapies for a Common Cardiology Condition